Gorky, Jonathan M.
Karinja, Sarah J.
Ranjeva, Sylvia L.
Liu, Lingshan
Smith, Matthew R.
Mueller, Ariel L.
Houle, Timothy T.
Eberlin, Kyle R.
Ruscic, Katarina J.
Funding for this research was provided by:
National Institute of General Medical Sciences (T32-GM007592)
International Anesthesia Research Society (Mentored Research Award)
Harvard Medical School (Eleanor and Miles Shore Award)
Article History
Received: 28 June 2024
Accepted: 7 October 2024
First Online: 18 October 2024
Declarations
:
: The study was approved and waived by the Massachusetts General Hospital Institutional Review Board (IRB), protocol 2021P002542, “Retrospective Chart Review to Assess Neuroma Hypersensitivity Reaction.” The requirement for written informed consent from patients was waived by the IRB.
: Not applicable. As the requirement for written informed consent was waived by the IRB, there is no consent needed for publication. No identifying images or personal or clinical details of participants are presented in this study.
: KRE is a consultant for AxoGen, Integra, Checkpoint, Tissium, Tulavi, and Biocircuit.